Your browser doesn't support javascript.
loading
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.
Joshi, Sunil K; Keck, Jamie M; Eide, Christopher A; Bottomly, Daniel; Traer, Elie; Tyner, Jeffrey W; McWeeney, Shannon K; Tognon, Cristina E; Druker, Brian J.
Affiliation
  • Joshi SK; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Keck JM; Department of Physiology & Pharmacology, School of Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Eide CA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Bottomly D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Traer E; Center for Spatial Systems Biomedicine, Oregon Health & Science University, Portland, OR, USA.
  • Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • McWeeney SK; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Tognon CE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Leukemia ; 34(10): 2798-2804, 2020 10.
Article in En | MEDLINE | ID: mdl-32366937
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Biomarkers, Tumor / Cell Transformation, Neoplastic / Receptor, ErbB-2 / Mutation Limits: Female / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Biomarkers, Tumor / Cell Transformation, Neoplastic / Receptor, ErbB-2 / Mutation Limits: Female / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: United States